MBX Capital

North America, New York, United States, New York

Description

MBX Capital is a venture capital partnership investing in early-stage healthcare, life sciences, and environmental health companies

Investor Profile

MBX Capital has backed more than 48 startups, with 5 new investments in the last 12 months alone. The firm has led 3 rounds, about 6% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

Concentrates on Series A, Seed, Series B rounds (top funding stages).
Majority of deals are located in United States, Canada, India.
Strong thematic focus on Health Care, Biotechnology, Medical.

Stage Focus

Series A (50%)
Seed (35%)
Series B (8%)
Series Unknown (6%)

Country Focus

United States (92%)
Canada (6%)
India (2%)

Industry Focus

Health Care
Biotechnology
Medical
Therapeutics
Medical Device
Information Technology
Life Science
Dental
Artificial Intelligence (Ai)
Pharmaceutical

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does MBX Capital frequently co-invest with?

Gaingels

North America, Vermont, United States, Burlington

Co-Investments: 3

Bossa Invest

South America, Sao Paulo, Brazil, São Paulo

Co-Investments: 2

FundRx

North America, New York, United States, New York

Co-Investments: 5

Amboy Street Ventures

North America, California, United States, Los Angeles

Co-Investments: 2

Graphene Ventures

North America, California, United States, Palo Alto

Co-Investments: 2

Metaplanet

Europe, Harjumaa, Estonia, Tallinn

Co-Investments: 2

AXA Venture Partners

Europe, Ile-de-France, France, Paris

Co-Investments: 3

Village Global

North America, California, United States, Covina

Co-Investments: 4

Abell Foundation

North America, Maryland, United States, Baltimore

Co-Investments: 2

Khosla Ventures

North America, California, United States, Menlo Park

Co-Investments: 4

Which angels does MBX Capital often collaborate with?

Zeshan Muhammedi

North America, New York, United States, New York

Shared Deals: 1

Vic Pirotsky

North America, Massachusetts, United States, Boston

Shared Deals: 1

Andrea (Andy) Coravos

North America, Massachusetts, United States, Boston

Shared Deals: 1

Michael Eisner

North America, California, United States, Beverly Hills

Shared Deals: 1

Hamid R. Moghadam

North America, California, United States

Shared Deals: 1

Dara Khosrowshahi

North America, California, United States

Shared Deals: 1

Bobby Yazdani

North America, California, United States, San Francisco

Shared Deals: 1

Anne Wojcicki

North America, California, United States, San Francisco

Shared Deals: 1

Andrew Izyumov

Europe, Cyprus

Shared Deals: 1

Will Smith

North America, Pennsylvania, United States, Philadelphia

Shared Deals: 1

What are some of recent deals done by MBX Capital?

Juniper Genomics

Toronto, Ontario, Canada

Juniper Genomics brings modern genomics and data science to help overcome barriers and challenges facing IVF patients.

SeedJun 26, 2025

Amount Raised: $4,600,000

Vivodyne

San Francisco, California, United States

Vivodyne accelerates drug discovery using lab-grown human tissues, robotics, and AI to generate accurate preclinical test data.

BiotechnologyLifestyleMedical

Series AMay 29, 2025

Amount Raised: $40,000,000

CND Life Sciences

Scottsdale, Arizona, United States

CND Life Sciences is a life sciences company that develops an evidence-based tool for detecting neurodegenerative diseases.

BiotechnologyHealth DiagnosticsLife ScienceMedical

Series AMay 1, 2025

Amount Raised: $13,500,000

Keebler Health

Durham, North Carolina, United States

Keebler Health is a developer of an AI-based risk adjustment tool for healthcare providers.

Artificial Intelligence (AI)BillingInformation Technology

SeedFeb 18, 2025

Amount Raised: $6,000,000

Tidal Vision

Bellingham, Washington, United States

Tidal Vision manufactures chitosan-based biomolecular solutions for some of humanity's chemistry and pollution.

AgricultureBiotechnologyManufacturing

Series BFeb 5, 2025

Amount Raised: $140,000,000

Waypoint Bio

New York, New York, United States

Optimizing cell therapy with spatial biology

Biotechnology

SeedJun 28, 2024

Amount Raised: $14,500,000

Vivodyne

Philadelphia, Pennsylvania, United States

Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.

BiotechnologyLifestyleMedical

SeedNov 22, 2023

Amount Raised: $38,000,000

Forum

New York, New York, United States

Forum helps people navigate life’s biggest challenges through the power of peer support groups.

Health CareMental Health

SeedNov 8, 2023

Amount Raised: $5,300,000

Macro Trials

Los Angeles, California, United States

Clinical trials. Reimagined.

BiopharmaClinical TrialsHealth CareLife Science

SeedJun 21, 2023

Amount Raised: $6,000,000

Thesis

New York, New York, United States

Thesis offers personalized brain supplements focused on mental performance.

Health CarePharmaceuticalWellness

SeedMay 2, 2023

Amount Raised: $5,100,000

MBX Capital

Description

Investor Profile

Investment Focus Highlights

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does MBX Capital frequently co-invest with?

Which angels does MBX Capital often collaborate with?

What are some of recent deals done by MBX Capital?

Ready to Raise Capital?

Pages

Free tools